Moreira, A

Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome. [electronic resource] - The British journal of dermatology 09 2018 - 747-749 p. digital

Publication Type: Case Reports; Journal Article

1365-2133

10.1111/bjd.16607 doi


Aged
Antibodies, Monoclonal, Humanized--administration & dosage
Basal Cell Nevus Syndrome--drug therapy
Humans
Infusions, Intravenous
Male
Mutation
Off-Label Use
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Repressor Proteins--genetics
Skin Neoplasms--drug therapy
Treatment Outcome